FDA cracks down on 7-OH products – article

The U.S. Food and Drug Administration (FDA) issued 7 warning letters to companies marketing products containing 7-hydroxymitragynine (7-OH), which is a synthesized and concentrated chemical found in trace amounts in kratom. Read mixed reactions from the industry to the move here.

GLP-what? Herbalife bucks trend with new fat burner formula – article

Instead of producing another product to support GLP-1 users, the MLM giant has launched a new weight management supplement featuring a more traditional blend of branded thermogenic ingredients. The new formulation includes Morosil, Metabolaid and Capsifen. Learn more here.

Health tech trailblazer Radicle Science launches Radicle Discovery Gen 2 – press release

Launching a next generation version of their pioneering Proof-as-a-Service platform, Radical Science introduces Radicle Discovery Gen 2. The new platform combines rigorous clinical trials, AI modeling, data aggregating and crowdsourcing to validate the effects of natural products across diverse populations. Learn more about this groundbreaking model here.

How to navigate tariff uncertainty – article

Trade groups and brands are taking actions to minimize impacts while trade negotiations continue and stakeholders worry current exclusions could disappear. Learn more and find out what Tom Chapman, co-CEO of the Organic Trade Association, suggests companies do to minimize tariff exposure here.

NDI process victim of Trump’s war on regulations – article

Cara Welch, Ph.D., director of the U.S. Food and Drug Administration’s Office of Dietary Supplement Programs, said final New Dietary Ingredient Notification (NDIN) guidance will be possible only after 10 other regulations have been eliminated as required by the Trump administration. “I would throw that out to industry to chime in on what regulations or policies could be removed,” she said. Plus, here’s the latest on the NDIN process from FDA. Learn more here.